Celgene Corp (NASDAQ:CELG)

88.95
Delayed Data
As of Apr 20
 -0.67 / -0.75%
Today’s Change
84.25
Today|||52-Week Range
147.17
-14.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line941.0M1.1B1.0B-81.0M
 
 
 
 
 
Depreciation121.0M119.0M115.0M116.0M
 
 
 
 
 
Total Other Cash Flow195.0M256.0M170.0M373.0M
 
 
 
 
 
Funds From Operations1.2B1.3B1.3B-727.0M
 
 
 
 
 
Funds From/For Other Operating Expenses324.0M-286.0M207.0M-2.4B
 
 
 
 
 
Net Cash Flow - Operating Activities853.0M1.6B1.1B1.7B
 
 
 
 
 
 
InvestingIncrease In Investments-1.9B-1.7B-3.5B-1.5B
 
 
 
 
 
Decrease In Investments266.0M1.8B1.2B2.7B
 
 
 
 
 
Capital Expenditures-62.0M-70.0M-44.0M-103.0M
 
 
 
 
 
Other Investing - Uses-----27.0M0.00
 
 
Other Investing - Sources4.0M-4.0M----
 
 
 
Net Cash Flow Investing-1.7B45.0M-2.4B1.1B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings------3.0B
 
 
Long Term Debt Reduction-------1.4B
 
 
Net Proceeds Stock Sale184.0M203.0M250.0M48.0M
 
 
 
 
 
Common Preferred Redeemed-293.0M-518.0M-114.0M-2.9B
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-109.0M-315.0M132.0M-1.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash19.0M41.0M5.0M7.0M
 
 
 
 
 
 
Net Change In Cash-916.0M1.3B-1.2B1.5B